Pacylex Pharmaceuticals Publishes a New Myristoylation Inhibitor Mechanism of Anti-Cancer Activity in Molecular Cancer Therapeutics ...

Discover important insights into the clonal evolution of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive ...

New report highlights variance in blood cancer types, with Hodgkin lymphoma having the highest five-year net survival ...

Vincerx (VINC) stock fell 20% after the company said it plans to seek out strategic partners for two drug candidates so that it can focus its resources on VIP943. Read more here.

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

(HealthDay News) — Overall survival (OS) after umbilical cord blood transplant (UCBT) has improved over time, according to a study published in Transplantation and Cellular Therapy.

For umbilical cord blood transplant (UCBT), overall survival has improved over time, according to a study published.

The National Cancer Registry of Ireland (NCRI) report covers cancers such as non-Hodgkin lymphoma, leukaemia, and multiple ...

Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent ...

People who develop blood cancers in Ireland now have increased chance of survival due to better diagnosis and treatment, according to a new report.